This meta-analysis reveals significant insights on cardiopulmonary exercise testing for mortality risk in hypertrophic cardiomyopathy, suggesting enhanced clinical utility.
Key Points
Cardiopulmonary exercise testing enhances mortality risk assessment in hypertrophic cardiomyopathy.
The hazard ratio for peak oxygen uptake showed significant mortality correlation of 0.86 (95% CI, 0.82-0.90).
A systematic review aggregated 60 studies on cardiopulmonary exercise testing in 12,914 hypertrophic cardiomyopathy patients.
Abnormal blood pressure response during exercise predicted a mortality hazard ratio of 2.29 (95% CI, 1.13-4.64).